International Bordetella Symposia
International Bordetella Symposia
批准号:
10469207
负责人:
Fredrick Heath Damron
金额:
$0.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-06-26 至 2023-05-31
关键词:
AcademiaAddressAdvertisingAntibiotic ResistanceAwardBacteriaBacterial InfectionsBordetellaBordetella pertussisBritish ColumbiaCOVID-19 pandemicCanadaCenters for Disease Control and Prevention (U.S.)Cessation of lifeChildClinicalCollaborationsCommunitiesDevelopmentEpidemiologyEventFosteringFunctional disorderFundingFunding OpportunitiesFutureGoalsHealthIncidenceIndividualInfectionInternationalLifeManufacturer NameMarylandMicrobiologyMinority WomenMissionNotificationParticipantPertussisPertussis VaccinePharmacologic SubstancePostdoctoral FellowPreventionPrivatizationProcessPublic HealthReportingResearchResearch PersonnelRespiratory DiseaseRespiratory Tract InfectionsScientistSeriesSocietiesStudentsTrainingTravelUnderrepresented MinorityUnited States National Institutes of HealthUniversitiesVaccinesWomanbasecostdata disseminationdata exchangegraduate studentinnovationinvestigator trainingmeetingsnext generationpathogenpathogenic bacteriapre-doctoralpreventable deathresearch and developmentsuccesssymposiumtranslational scientistundergraduate studentvaccine development
中文摘要
项目摘要/摘要:
百日咳,又称百日咳,是一种由细菌病原体波氏杆菌引起的呼吸道疾病。
百日咳。百日咳是世界上可疫苗预防的死亡的主要原因之一,目前是唯一
发病率正在增加的疫苗可预防的细菌性疾病。尽管疫苗覆盖率很高,但欢呼
咳嗽(百日咳)再次成为美国和世界的一个主要公共卫生问题。最近,它是
估计有2400万例百日咳病例和160700例5岁以下儿童死亡
每年一次的世界。除了在2015年被列入美国国立卫生研究院新兴传染病病原体名单外,美国疾病控制与预防中心
最近在2019年抗生素耐药性威胁报告中将百日咳杆菌列入其新的观察名单
因为这种高传染性细菌未来的负担是未知的。自20世纪60年代以来,S,波尔德泰拉
研究界组织了一次国际波尔德特拉研讨会,第12届研讨会在
布鲁塞尔大学卡米尔·洛希特博士于2019年4月发表。为了努力增加新数据的传播和
思想交流,Ciaran Skerry博士在马里兰大学主持了有史以来第一个波尔德泰拉研究日
2018年4月。波尔德泰拉研究日是波尔德泰拉研究人员在美国举行的一次会议
在国际波尔德泰拉研讨会的淡季举行会议。由于新冠肺炎大流行,两者
2020年波尔德泰拉研究日和2021年波尔德泰拉国际研讨会被推迟。至
继续传播重要研究成果,国际波尔德特拉学会主办了一次基于ZOOM的
2020年8月举行的一次会议,学术界、疾病控制与预防中心、FDA、NIH和许多
制药公司。这一在线活动的重大成功导致波尔德泰拉协会创建了一个
每月实验室会议系列,世界各地的不同团体可以在这里展示他们的最新研究。在……里面
为了进一步支持下一代科学家的发展,这款R13应用程序请求
资助初级科学家(博士后和博士后)参加和演讲的旅费相关费用
在不列颠哥伦比亚大学举办的第13届国际波尔德泰拉研讨会上的创新研究
加拿大温哥华(2022年6月)。
英文摘要
Project Summary/Abstract:
Whooping cough, also known as Pertussis, is a respiratory disease caused by the bacterial pathogen Bordetella
pertussis. Pertussis is one of the world’s leading causes of vaccine-preventable deaths and is currently the only
vaccine-preventable bacterial disease that is increasing in incidence. Despite high vaccine coverage, whooping
cough (pertussis) has re-emerged as a major public health concern in the US and the world. Recently, it was
estimated that there were 24 million pertussis cases and 160,700 deaths in children younger than 5 years around
the world per year. In addition to being added to the NIH emerging infectious pathogens list in 2015, the CDC
recently listed Bordetella pertussis on its new Watch List in the 2019 Antibiotic Resistance Threats Report
because of the unknown future burden of this highly contagious bacterium. Since the 1960’s, the Bordetella
research community has organized an International Bordetella Symposium, the 12th symposium was hosted at
Brussels University by Dr. Camille Locht, in April of 2019. In an effort to increase dissemination of new data and
exchange of ideas, Dr. Ciaran Skerry hosted the 1st ever Bordetella Research Day at the University of Maryland
in April, 2018. The Bordetella Research Day was meant to be a U.S-based conference for Bordetella researchers
to meet during the off years of the International Bordetella Symposiums. Due to the COVID-19 pandemic, both
the 2020 Bordetella Research Day, and the 2021 International Bordetella Symposium were postponed. To
continue dissemination of important research, the International Bordetella Society hosted a zoom-based
conference in August 2020 which garnered attendance from academia, the CDC, FDA, NIH, and many
pharmaceutical companies. The major success of this online event resulted in the Bordetella Society creating a
monthly Lab Meeting Series, where different groups around the world can showcase their latest research. In
order to further support the development of the next generation of scientists, this R13 application is requesting
funds to support travel associated costs for junior scientists (pre- and post-doctoral) to attend and present
innovative research at the 13th International Bordetella Symposium hosted at the University of British Columbia
in Vancouver, Canada (June 2022).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
13th International Bordetella Symposium
-
批准号:10506485
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2022
-
负责人:Fredrick Heath Damron
-
依托单位:
Development of mRNA-platform vaccines
-
批准号:10211558
-
项目类别:
-
资助金额:$82.63万
-
财政年份:2021
-
负责人:Fredrick Heath Damron
-
依托单位:
Development of mRNA-platform vaccines
-
批准号:10331084
-
项目类别:
-
资助金额:$83.39万
-
财政年份:2021
-
负责人:Fredrick Heath Damron
-
依托单位:
Development of mRNA-platform vaccines
-
批准号:10541207
-
项目类别:
-
资助金额:$84.15万
-
财政年份:2021
-
负责人:Fredrick Heath Damron
-
依托单位:
Development of mucosal vaccines to protect against pertussis
-
批准号:10333333
-
项目类别:
-
资助金额:$52.91万
-
财政年份:2019
-
负责人:Fredrick Heath Damron
-
依托单位:
Development of mucosal vaccines to protect against pertussis
-
批准号:10548222
-
项目类别:
-
资助金额:$58.56万
-
财政年份:2019
-
负责人:Fredrick Heath Damron
-
依托单位:
Development of mucosal vaccines to protect against pertussis
-
批准号:10084257
-
项目类别:
-
资助金额:$59.22万
-
财政年份:2019
-
负责人:Fredrick Heath Damron
-
依托单位:
海外基金